A detailed history of Tucker Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tucker Asset Management LLC holds 158 shares of BMY stock, worth $9,301. This represents 0.0% of its overall portfolio holdings.

Number of Shares
158
Previous 168 5.95%
Holding current value
$9,301
Previous $9.11 Million 27.98%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$40.25 - $52.99 $402 - $529
-10 Reduced 5.95%
158 $6.56 Million
Q1 2024

Aug 09, 2024

BUY
$47.98 - $54.4 $1,295 - $1,468
27 Added 19.15%
168 $9.11 Million
Q4 2023

Mar 04, 2024

SELL
$48.48 - $57.85 $242 - $289
-5 Reduced 3.42%
141 $7.24 Million
Q3 2023

Dec 04, 2023

BUY
$57.89 - $64.73 $2,894 - $3,236
50 Added 52.08%
146 $8.47 Million
Q2 2023

Sep 08, 2023

SELL
$63.71 - $70.74 $445 - $495
-7 Reduced 6.8%
96 $6.14 Million
Q1 2023

May 11, 2023

BUY
$65.71 - $74.53 $788 - $894
12 Added 13.19%
103 $7.14 Million
Q3 2022

May 11, 2023

BUY
$0.13 - $76.84 $0 - $384
5 Added 5.49%
96 $7.44 Million
Q2 2022

May 11, 2023

BUY
$72.62 - $79.98 $5,301 - $5,838
73 Added 405.56%
91 $7.01 Million
Q1 2022

May 11, 2023

BUY
$61.48 - $73.72 $5,594 - $6,708
91 New
91 $6.65 Million
Q4 2021

May 11, 2023

SELL
$53.63 - $62.52 $4,558 - $5,314
-85 Reduced 82.52%
18 $1.13 Million
Q1 2021

Aug 10, 2023

SELL
$59.34 - $66.74 $5,043 - $5,672
-85 Reduced 82.52%
18 $1.14 Million
Q4 2020

Jun 07, 2023

SELL
$57.74 - $65.43 $4,907 - $5,561
-85 Reduced 82.52%
18 $1.12 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Tucker Asset Management LLC Portfolio

Follow Tucker Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tucker Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tucker Asset Management LLC with notifications on news.